Teva- Pharmaceutical Industries Ltd. - ADR
TEVA
Market Cap$17.94B
Close$
$-4.43
126.4% downside
Current Fair Value
126.4% downsideOvervalued by 126.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $17.94 Billion |
|---|---|
| Enterprise Value | $34.59 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-0.5 |
| Beta | 0.52 |
| Outstanding Shares | 1,120,992,397 |
| Avg 30 Day Volume | 11,336,756 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -32.14 |
|---|---|
| PEG | 99.84 |
| Price to Sales | 1.2 |
| Price to Book Ratio | 2.8 |
| Enterprise Value to Revenue | 2.16 |
| Enterprise Value to EBIT | 10.39 |
| Enterprise Value to Net Income | -71 |
| Total Debt to Enterprise | 0.57 |
| Debt to Equity | 2.7 |
Revenue Sources
No data
ESG Score
No data
About Teva- Pharmaceutical Industries Ltd.
CEO: Kaare Schultz